Stanley Bukofzer
2018 - Egalet
In 2018, Stanley Bukofzer earned a total compensation of $2.2M as Senior Vice President and Chief Scientific and Technical Officer at Egalet.
Compensation breakdown
Non-Equity Incentive Plan | $260,873 |
---|---|
Salary | $375,012 |
Stock Awards | $1,556,773 |
Other | $6,054 |
Total | $2,198,712 |
Bukofzer received $1.6M in stock awards, accounting for 71% of the total pay in 2018.
Bukofzer also received $260.9K in non-equity incentive plan, $375K in salary and $6.1K in other compensation.
Rankings
In 2018, Stanley Bukofzer's compensation ranked 5,241st out of 14,244 executives tracked by ExecPay. In other words, Bukofzer earned more than 63.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,241 out of 14,244 | 63rd |
Division Manufacturing | 1,980 out of 5,765 | 66th |
Major group Chemicals And Allied Products | 720 out of 2,128 | 66th |
Industry group Drugs | 601 out of 1,817 | 67th |
Industry Pharmaceutical Preparations | 464 out of 1,391 | 67th |
Source: SEC filing on April 20, 2020.
Bukofzer's colleagues
We found six more compensation records of executives who worked with Stanley Bukofzer at Egalet in 2018.
2018
Arthur Higgins
Egalet
Chief Executive Officer
2018
Robert Radie
Egalet
Chief Executive Officer
2018
Daniel Peisert
Egalet
Chief Financial Officer
2018
Mark Strobeck
Egalet
Chief Operating Officer
2018
Stan Musial
Egalet
Chief Financial Officer
2018
Patrick Shea
Egalet
Former Senior Vice President and Chief Commercial Officer
News
Assertio Holdings CEO Arthur Higgins' 2020 pay falls 48% to $2.5M
April 12, 2021
Egalet CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
DepoMed CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
Egalet CEO Arthur Higgins' 2018 pay stays at $4.8M
November 6, 2019
DepoMed CEO Arthur Higgins' 2018 pay stays at $4.8M
April 8, 2019